Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ELUT - Elutia Inc - Ordinary Shares - Class A


IEX Last Trade
4.09
-0.010   -0.244%

Share volume: 42,205
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$4.10
-0.01
-0.24%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
36%
Profitability 50%
Dept financing 26%
Liquidity 13%
Performance 31%
Company vs Stock growth
vs
Performance
5 Days
1.74%
1 Month
12.95%
3 Months
27.33%
6 Months
19.36%
1 Year
169.74%
2 Year
-41.43%
Key data
Stock price
$4.09
P/E Ratio 
-1.87
DAY RANGE
N/A - N/A
EPS 
-$2.93
52 WEEK RANGE
$1.10 - $5.24
52 WEEK CHANGE
$1.81
MARKET CAP 
121.962 M
YIELD 
N/A
SHARES OUTSTANDING 
29.747 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$26,696
AVERAGE 30 VOLUME 
$54,006
Company detail
CEO:
Region: US
Website: aziyobio.com
Employees: 162
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

aziyo was created by highcape partners and tissue banks international with the mission of restoring health and mobility to the greatest number of patients. our vision for aziyo is to impact healthcare as the premier partner in innovation of new solutions that realize the potential of regenerative medicine. honoring the gift from those who selfishly give the precious gift of donation to those who receive it, we are committed to honoring the lives of these brave individuals and their families everyday. whether you need a traditional bone graft, a processed osteobiologic, or a custom musculoskeletal tissue product, aziyo is committed to innovating new solutions that help fulfill the promise of regenerative medicine. at aziyo, we foster a collaborative environment where we deliver best-in-class solutions and operational excellence to our customers each and every day.

Recent news